Search Results - "Yarovoi, Serge"
-
1
Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes
Published in Blood (25-11-2021)“…Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder mediated by ultra-large immune complexes (ULICs) containing immunoglobulin G (IgG)…”
Get full text
Journal Article -
2
Atomic description of the immune complex involved in heparin-induced thrombocytopenia
Published in Nature communications (22-09-2015)“…Heparin-induced thrombocytopenia (HIT) is an autoimmune thrombotic disorder caused by immune complexes containing platelet factor 4 (PF4), antibodies to PF4…”
Get full text
Journal Article -
3
Modulation of ultralarge immune complexes in heparin–induced thrombocytopenia
Published in Journal of thrombosis and haemostasis (01-03-2023)“…Heparin–induced thrombocytopenia (HIT) is a serious thrombotic disorder caused by ultralarge immune complexes (ULICs) containing platelet factor 4 (PF4) and…”
Get full text
Journal Article -
4
Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice
Published in Blood (16-04-2015)“…Persistent intracerebral hemorrhage (ICH) is a major cause of death and disability after traumatic brain injury (TBI) for which no medical treatment is…”
Get full text
Journal Article -
5
Dynamic antibody-binding properties in the pathogenesis of HIT
Published in Blood (02-08-2012)“…Rapid laboratory assessment of heparin-induced thrombocytopenia (HIT) is important for disease recognition and management. The utility of contemporary…”
Get full text
Journal Article -
6
Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits
Published in American journal of physiology. Lung cellular and molecular physiology (01-01-2018)“…Elevated active plasminogen activator inhibitor-1 (PAI-1) has an adverse effect on the outcomes of intrapleural fibrinolytic therapy (IPFT) in…”
Get more information
Journal Article -
7
Novel diagnostic assays for heparin-induced thrombocytopenia
Published in Blood (02-05-2013)“…Laboratory testing for heparin-induced thrombocytopenia (HIT) has important shortcomings. Immunoassays fail to discriminate platelet-activating from…”
Get full text
Journal Article -
8
Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia
Published in Blood advances (29-11-2016)“…Heparin-induced thrombocytopenia (HIT) is a thrombotic disorder initiated by antibodies to complexes between platelet factor 4 (PF4) and heparin. The risk of…”
Get full text
Journal Article -
9
Distinct Specificity and Single-molecule Kinetics Characterize the Interaction of Pathogenic and Non-pathogenic Antibodies against Platelet Factor 4-Heparin Complexes with Platelet Factor 4
Published in The Journal of biological chemistry (15-11-2013)“…Heparin-induced thrombocytopenia (HIT) is a thrombotic complication of heparin therapy mediated by antibodies to complexes between platelet factor 4 (PF4) and…”
Get full text
Journal Article -
10
Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia
Published in Blood (21-06-2012)“…Patients with heparin-induced thrombocytopenia (HIT) remain at risk for recurrent thromboembolic complications despite improvements in management. HIT is…”
Get full text
Journal Article -
11
RETRACTED ARTICLE: Release of IL-6 After Stroke Contributes to Impaired Cerebral Autoregulation and Hippocampal Neuronal Necrosis Through NMDA Receptor Activation and Upregulation of ET-1 and JNK
Published in Translational stroke research (01-02-2019)“…The sole FDA-approved drug treatment for ischemic stroke is tissue-type plasminogen activator (tPA). However, upregulation of JNK mitogen-activated protein…”
Get full text
Journal Article -
12
Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration
Published in Biochemical journal (15-04-2012)“…uPA (urokinase-type plasminogen activator) stimulates cell migration through multiple pathways, including formation of plasmin and extracellular…”
Get more information
Journal Article -
13
Signal Recognition Particle Components in the Nucleolus
Published in Proceedings of the National Academy of Sciences - PNAS (04-01-2000)“…The signal recognition particle (SRP) is a ribonucleoprotein composed of an Alu domain and an S domain. The S domain contains unique sequence SRP RNA and four…”
Get full text
Journal Article -
14
Fc-Modified Kko: A Novel Therapeutic for Heparin-Induced Thrombocytopenia (HIT), Reversing Both the Thrombocytopenia and Thrombosis
Published in Blood (23-11-2021)“…Heparin induced thrombocytopenia (HIT) is an immunogenic prothrombotic disorder caused by antibodies that recognize human platelet factor 4 (PF4) complexed to…”
Get full text
Journal Article -
15
Modulation of Ultralarge Immune Complexes in Heparin-Induced Thrombocytopenia
Published in Blood (15-11-2022)Get full text
Journal Article -
16
Release of IL-6 After Stroke Contributes to Impaired Cerebral Autoregulation and Hippocampal Neuronal Necrosis Through NMDA Receptor Activation and Upregulation of ET-1 and JNK
Published in Translational stroke research (01-02-2019)“…The sole FDA-approved drug treatment for ischemic stroke is tissue-type plasminogen activator (tPA). However, upregulation of JNK mitogen-activated protein…”
Get full text
Journal Article -
17
-
18
Complement Regulates the Procoagulant Effects of HIT Immune Complexes
Published in Blood (05-11-2020)“…Heparin induced thrombocytopenia (HIT) is a prothrombotic disorder mediated by ultra-large immune complexes (ULICs) containing IgG antibodies bound to…”
Get full text
Journal Article -
19
Abstract TP251: Release of IL-6 After Stroke Contributes to Impaired Cerebral Autoregulation and Hippocampal Neuronal Necrosis Through NMDA Receptor Activation and Upregulation of ET-1 and JNK
Published in Stroke (1970) (22-01-2018)“…Abstract only Introduction: The sole FDA approved drug treatment for acute stroke is tissue type plasminogen activator (tPA). However, its brief therapeutic…”
Get full text
Journal Article -
20
Vaccine-Induced Thrombocytopenia and Thrombosis (VITT) Antibodies Recognize Neutrophil-Activating Peptide 2 (NAP2) As Well As Platelet Factor 4 (PF4): Mechanistic and Clinical Implications
Published in Blood (23-11-2021)“…VITT is an immune-based complication of adenoviral-based vaccines used to immunize against SARS_CoV2. The antibodies in VITT have been described as directed at…”
Get full text
Journal Article